NIEN-CHING Han
Seminars
Thursday 20th November 2025
Innovative Cap Analog Design Advancing mRNA-Based Therapeutics
10:30 am
- Novel cap analogs are synthesized through rational design to minimize IFIT1 interaction, named HiXCaps
- HiXCaps capped mRNA demonstrates elevated translation efficiency under conditions where interferon responses are activated
- Presenting case studies on mRNA vaccines utilizing HiXCaps
